History of meningococcal vaccines and their serological correlates of protection

被引：52

作者：

Vipond, Caroline ^{[1
]}

Care, Rory ^{[1
]}

Feavers, Ian M. ^{[1
]}

机构：

[1] NIBSC, Div Bacteriol, Potters Bar EN6 3QG, Herts, England

来源：

VACCINE | 2012年 / 30卷

关键词：

Vaccine; Meningitis; Polysaccharide; Outer membrane vesicle; Serological correlate; Complement; Bactericidal antibody; Gene expression; OUTER-MEMBRANE PROTEIN; C CONJUGATE VACCINE; MENINGITIDIS GROUP-B; FACTOR-H BINDING; NEISSERIA-MENINGITIDIS; SEROGROUP-C; GROUP-A; IMMUNE-RESPONSE; VESICLE VACCINE; POLYSACCHARIDE VACCINE;

D O I：

10.1016/j.vaccine.2011.12.060

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

For over a hundred years Neisseria meningitidis has been known to be one of the major causes of bacterial meningitis. However, effective vaccines were not developed until the latter part of the 20th century. The first of these were based on purified high molecular weight capsular polysaccharides and more recently the development of glycoconjugate vaccines has made paediatric immunisation programmes possible. The prevention of group B meningococcal disease has remained a challenge throughout this period. This review charts the history of the development of meningococcal vaccines and the importance of serological correlates of protection in their evaluation. (C) 2012 Elsevier Ltd. All rights reserved.

引用

页码：B10 / B17

页数：8

共 125 条

[11] EFFICACY, SAFETY, AND IMMUNOGENICITY OF A MENINGOCOCCAL GROUP-B (15-P1.3) OUTER-MEMBRANE PROTEIN VACCINE IN IQUIQUE, CHILE [J].

BOSLEGO, J ;

GARCIA, J ;

CRUZ, C ;

ZOLLINGER, W ;

BRANDT, B ;

RUIZ, S ;

MARTINEZ, M ;

ARTHUR, J ;

UNDERWOOD, P ;

SILVA, W ;

MORAN, E ;

HANKINS, W ;

GILLY, J ;

MAYS, J .

VACCINE, 1995, 13 (09) :821-829

[12] Meningococcal C conjugate vaccine: The experience in England and Wales [J].

Campbell, Helen ;

Borrow, Ray ;

Salisbury, David ;

Miller, Elizabeth .

VACCINE, 2009, 27 :B20-B29

[13]

Cano R, 2004, Euro Surveill, V9, P11, DOI 10.2807/esm.09.07.00474-en

[14] IMMUNIZATION WITH SYNTHETIC PEPTIDES CONTAINING EPITOPES OF THE CLASS-1 OUTER-MEMBRANE PROTEIN OF NEISSERIA-MENINGITIDIS - PRODUCTION OF BACTERICIDAL ANTIBODIES ON IMMUNIZATION WITH A CYCLIC PEPTIDE [J].

CHRISTODOULIDES, M ;

MCGUINNESS, BT ;

HECKELS, JE .

JOURNAL OF GENERAL MICROBIOLOGY, 1993, 139 :1729-1738

[15] Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine [J].

Claassen, I ;

Meylis, J ;

vanderLey, P ;

Peeters, C ;

Brons, H ;

Robert, J ;

Borsboom, D ;

vanderArk, A ;

vanStraaten, I ;

Roholl, P ;

Kuipers, B ;

Poolman, J .

VACCINE, 1996, 14 (10) :1001-1008

[16] Capsule null locus meningococci: Typing of antigens used in an investigational multicomponent meningococcus serogroup B vaccine [J].

Claus, Heike ;

Jordens, Markus S. ;

Kriz, Pavla ;

Musilek, Martin ;

Jarva, Hanna ;

Pawlik, Marie-Christin ;

Meri, Seppo ;

Vogel, Ulrich .

VACCINE, 2012, 30 (02) :155-160

[17] Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands [J].

de Greeff, SC ;

de Melker, HE ;

Spanjaard, L ;

Schouls, LM ;

van DerEnde, A .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (01) :79-80

[18] Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2-3 and 7-8 years of age [J].

de Kleijn, ED ;

de Groot, R ;

Labadie, J ;

Lafeber, AB ;

van den Dobbelsteen, G ;

van Alphen, L ;

van Dijken, H ;

Kuipers, B ;

van Omme, GW ;

Wala, M ;

Juttmann, R ;

Rümke, HC .

VACCINE, 2000, 18 (15) :1456-1466

[19]

DEMORAES JC, 1992, LANCET, V340, P1074

[20] RELEASE OF ENDOTOXIN IN FORM OF CELL-WALL BLEBS DURING IN-VITRO GROWTH OF NEISSERIA-MENINGITIDIS [J].

DEVOE, IW ;

GILCHRIS.JE .

JOURNAL OF EXPERIMENTAL MEDICINE, 1973, 138 (05) :1156-1167

← 1 2 3 4 5 6 7 8 9 10 →